Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BioArctic AB (publ)
BRCTFCurrent price
13.72 USD
0 USD (0.00%)
Last closed
146.6 SEK
Company
www.bioarctic.se
ISIN
SE0010323311
Sector
Healthcare
Industry
Biotechnology
Exchange
ST
Capitalization
12 703 460 157 SEK
Yield for 12 month
-28.97 %
1Y
3Y
5Y
10Y
15Y
BRCTF
BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden. Address: Warfvinges vag 35, Stockholm, Sweden, 112 51
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 920.34 SEKP/E ratio
–Dividend Yield
–Current Year
+617 480 336 SEK
Last Year
+228 841 475 SEK
Current Quarter
+49 964 185 SEK
Last Quarter
+29 710 467 SEK
Current Year
+347 152 075 SEK
Last Year
+154 336 251 SEK
Current Quarter
+45 141 584 SEK
Last Quarter
+27 469 075 SEK
Key Figures BRCTF
1 year
3 years
5 years
10 years
EBITDA
-74 547 324 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-5.24 %
PEG Ratio
–
Return On Equity TTM
-9.18 %
Wall Street Target Price
3 920.34 SEK
Revenue TTM
300 067 793 SEK
Book Value
10.55 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1742 %
Dividend Yield
–
Gross Profit TTM
155 910 040 SEK
Earnings per share
-1 SEK
Diluted Eps TTM
-1 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-8.4 %
Profit Margin
-29.49 %
Dividend Analytics BRCTF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
155 %Dividend History BRCTF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
10.05.2019
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BRCTF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
294.1176
Enterprise Value Revenue
40.8989
Price Sales TTM
42.3353
Enterprise Value EBITDA
1047.7391
Price Book MRQ
13.6361
Financials BRCTF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BRCTF
For 52 weeks
142.34 SEK
289.1 SEK
50 Day MA
163.01 SEK
Shares Short Prior Month
–
200 Day MA
199.1 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart